Effect of Allopurinol on Left Ventricular Function in Children With Dilated Cardiomyopathy
NCT05193838 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2022-01-18
Summary
The aim of this study is to detect effect of allopurinol supplementation in pediatric patients with dilated cardiomyopathy.
Conditions
- Dilated Cardiomyopathy
Interventions
- DRUG
-
Allopurinol Tablet
examined patients with dilated cardiomyopathy will receive allopurinol for 6 months
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 1 Year
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-05-01
- Primary Completion
- 2023-05-31
- Completion
- 2023-07-31
More Related Trials
-
Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management (MYOPED)
NCT06591260 ·Status: RECRUITING
-
Ambrisentan in Single Ventricle
NCT02080637 ·Status: COMPLETED ·Phase: PHASE2
-
Simvastatin Therapy in Patients With Dilated Cardiomyopathy.
NCT03775070 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing the Effects of Amiodarone, Sotalol, and Placebo in Maintaining Sinus Rhythm in Patients With Atrial Fibrillation Converted to Sinus Rhythm
NCT00007605 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy
NCT07241104 ·Status: RECRUITING ·Phase: PHASE1
-
The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic Dysfunction
NCT05045274 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Sulcardine Sulfate Tablets in Patients With Premature Ventricular Contractions
NCT01235156 ·Status: UNKNOWN
-
Randomized Double-blind Trial to Study the Benefit of Colchicine in Patients With Acutely Decompensated Heart Failure
NCT04705987 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Efficacy of ARNI Versus ACE Inhibitor Therapy in Egyptian Children With Dilated Cardiomyopathy
NCT07197372 ·Status: NOT_YET_RECRUITING
-
Natriuretic Peptides as a Prognostic and Risk Stratification Tool in Assessment of Valvular Heart Disease
NCT05439369 ·Status: UNKNOWN
-
Study of Colchicine to Treat Acute Pericarditis and Prevent Recurrences
NCT00128453 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Colchicine to Treat and Prevent Recurrent Pericarditis (First Episode)
NCT00128414 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL180
NCT00907998 ·Status: COMPLETED ·Phase: PHASE1
-
PK/PD of Digoxin in Infants With SVHD
NCT06613477 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Role of Amino Acids and Genetic Disorder in Pathogenesis of Heart Failure
NCT03590522 ·Status: UNKNOWN
-
Effect of Sodium Glucose Cotransporter 2 Inhibitiors on Left Ventricular Remodeling Among Diabetic and Non Diabetic Patients With Chronic Heart Failure
NCT06137430 ·Status: NOT_YET_RECRUITING
-
Effect of Dapagliflozin on VT in Patients With Heart Failure.
NCT05550441 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart Failure
NCT00505336 ·Status: COMPLETED ·Phase: NA
-
Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
NCT03593317 ·Status: RECRUITING ·Phase: PHASE2
-
The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation
NCT04217135 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD)
NCT00568594 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
"ALOFT - Aliskiren Observation of Heart Failure Treatment": Efficacy and Safety of Aliskiren Added on Top of Standard Therapy in Adults (≥ 18 Years) With Stable Heart Failure
NCT00219011 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction Between Aliskiren and Furosemide in Patients With Heart Failure
NCT01125514 ·Status: COMPLETED ·Phase: PHASE2
-
Enalapril After Anthracycline Cardiotoxicity
NCT00000547 ·Status: COMPLETED ·Phase: PHASE3
-
Risk Analysis of Cardiotoxic Medication Use Due to Sodium Arsenite Chloride Injection
NCT06060132 ·Status: UNKNOWN